Pfizer's Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with ...

M3GAN 2.0 takes that tradition to terrifying new extremes, particularly thanks to the unforgettable presence of Amelia. As ...

In “Sick and Dirty,” author Michael Koresky takes a clear-eyed look at golden age Hollywood’s stealth queerness on screen.

Justin Tucker, one of the best kickers in NFL history, suspended for 10 weeks after 16 women said he was sexually ...

The Democrat will be the first woman and one of fewer than 20 Minnesotans accorded the honor. She will lie in state with her ...

Nearly a year after her mother was sentenced to prison for defrauding Inuit organizations to help pay for her education, an ...

The United Arab Emirates has expressed its solidarity with the Central African Republic following the deaths and injuries of ...

Nick Kyrgios has admitted he feels for Emma Raducanu amid her struggle to compete with tennis’ elite again. Raducanu became ...

Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors: New York Friday, June 27, 2025, 10:00 Hrs [IST] Pfizer Inc. announced ...

GAINESVILLE, Fla. (WCJB) - Florida Congresswoman Kat Cammack’s Gainesville and Ocala offices remain temporarily closed ...

The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...